Form 4: Lam Research Director Sells Shares Under 10b5-1 Plan

Lam Research Director Eric Brandt reported the sale of common stock under a pre-arranged trading plan.

Summary

• Director Eric Brandt of Lam Research Corporation (LRCX) executed a series of stock sales on June 11, 2026.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on February 6, 2026.
• A total of 32,770 shares of common stock were sold across multiple transactions.
• The sales occurred at weighted average prices ranging from $337.00 to $364.37 per share.
• Following these transactions, Brandt's beneficial ownership of Lam Research common stock is reported as 199,205 shares, which includes shares subject to unvested restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider stock sale executed under a pre-arranged plan, which is a common practice and does not inherently signal positive or negative company performance.

Negatives

• Director Eric Brandt sold a significant number of shares (32,770) under a pre-arranged plan.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to insider stock transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Lam Research, are standard disclosures for insider stock transactions. The use of a Rule 10b5-1 plan indicates a structured approach to stock sales, often employed by executives to diversify holdings or manage personal finances without appearing to trade on material non-public information.

Stakeholder Impact

• Shareholders may view insider selling with caution, although the use of a Rule 10b5-1 plan mitigates concerns about trading on non-public information.

Key Dates

Keywords

Lam Research, LRCX, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Director, Beneficial Ownership